CA 19-9 (Carbohydrate Antigen 19-9 — Pancreatic & Biliary Marker)
Also known as: Cancer Antigen 19-9, Pancreatic Cancer Blood Test, GI Tumor Marker CA19-9, Sialyl Lewis Antigen, CA19.9
Parameters Measured in the Report
A breakdown of individual biomarkers and biological reference intervals typically found in your report:
| Biomarker | Standard Range | Unit | What It Means |
|---|---|---|---|
Serum CA 19-9 (Carbohydrate Antigen 19-9) | Normal: < 37.0 (Malignancy Suspicion: > 37.0–100.0 Advanced / Metastatic: > 100.0–1,000+) | U/mL | Epithelial glycoprotein tumor marker; primary surveillance marker for pancreatic adenocarcinoma and cholangiocarcinoma. |
* Note: Reference ranges may vary slightly between testing instruments and reagent kits. Always refer to the reference interval printed on your specific pathology report.
Clinical Focus
Circulating concentration of sialylated Lewis-a pentasaccharide glycoprotein tumor antigen shed by gastrointestinal adenocarcinomas.
Sample & Specimen
Venous blood (Serum tube)
Fasting Protocol
No fasting required. Maintain regular water intake.
Turnaround Time
12–24 hours
What Is This Test?
Why Did Your Doctor Order This Test?
Physicians routinely prescribe the CA 19-9 in the following clinical scenarios:
How to Prepare Before Your Test
- No fasting or special preparation required.
- Note: Approximately 5% to 10% of the human population genetically lacks the Lewis enzyme (Lewis negative phenotype Le a-b-) and cannot synthesize CA 19-9 even in advanced pancreatic cancer.
Understanding Your Results
What higher or lower readings generally mean in clinical practice:
If Values Are Higher Than Normal
Markedly elevated CA 19-9 (>100–1,000+ U/mL) in the presence of a pancreatic mass or biliary dilation strongly indicates pancreatic or biliary adenocarcinoma, with values >1,000 U/mL virtually always indicating unresectable or metastatic disease. However, benign biliary obstruction (gallstones/cholangitis) can also cause temporary elevations up to 500 U/mL that normalize once the bile duct is cleared.
If Values Are Lower Than Normal
A normal CA 19-9 (<37.0 U/mL) is expected in healthy adults. During post-treatment surveillance, maintaining low baseline levels confirms disease control.
Frequently Asked Questions
Why isn’t CA 19-9 used as a routine screening test for pancreatic cancer in healthy people?
CA 19-9 has low sensitivity in early resectable tumors and low specificity in the general population. Benign conditions like gallstones, liver cirrhosis, pancreatitis, or thyroid disease cause false-positive elevations, leading to unnecessary anxiety and invasive procedures.
Why do some pancreatic cancer patients have completely normal CA 19-9 levels?
About 10% of the population carries a genetic variation (Lewis negative Le a-b-) that makes them biologically unable to produce the CA 19-9 sugar molecule. In these individuals, pancreatic tumors cannot secrete CA 19-9, so oncologists rely on imaging and CEA instead.
Related Laboratory Tests
Tests frequently prescribed together or used as follow-up investigations:
CEA (Carcinoembryonic Antigen — Colorectal Tumor Marker)
Circulating concentration of oncofetal cell-surface glycoprotein involved in cellular adhesion, shed by gastrointestinal adenocarcinomas.
Liver Function Test (LFT / Hepatic Panel)
Bilirubin fractions, transaminases (ALT/SGPT, AST/SGOT), Alkaline Phosphatase (ALP), and proteins (Albumin, Globulin).
Serum Amylase & Lipase (Pancreatic Enzymes)
Digestive enzyme concentrations manufactured by pancreatic acinar cells and secreted into the duodenum.
Alpha-Fetoprotein (AFP — Liver & Germ Cell Tumor Marker)
Circulating concentration of oncofetal plasma glycoprotein synthesized by fetal yolk sac and fetal hepatocytes.
Medical & Diagnostic Disclaimer
This guide is published for educational and patient informational purposes only. It is not a substitute for professional medical evaluation, diagnosis, or clinical advice.
A laboratory result that falls slightly outside standard statistical reference intervals does not automatically indicate disease; conversely, a normal result does not guarantee the absence of medical conditions. Only your attending physician can interpret lab findings in the context of your medical history, physical exam, and symptoms.